Biopharmaceutical company Propanc Biopharma announced that it will acquire $100 million in ETH
-
最新报道：According to Bijie.com, biopharmaceutical company Propanc Biopharma announced today that it plans to acquire $100 million worth of Ethereum over the next 12 months. The company said the move will enhance its corporate strategy across various areas, including cryptocurrency investment, drug development, and asset acquisition. (Globenewswire)
下一篇
Tron Inc. Receives $110 Million Investment from Major Shareholder, Expanding TRX Holdings Value to $220 Million
- Tron Inc. (NASDAQ: TRON) announced today (September 2nd) that its largest shareholder, Bra...
24小时热点
热点专题
418154